Acelyrin shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Acelyrin
Tip: Access up to 7 years of quarterly data
All positions including Acelyrin held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Acelyrin by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $135k | 43k | 3.14 |
2024-09-30 | $211k | 43k | 4.93 |
2024-06-30 | $189k | 43k | 4.41 |
2023-12-31 | $136k | 18k | 7.46 |
2023-09-30 | $185k | 18k | 10.17 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors